Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Laryngoscope. 2017 Mar 17;127(8):E270–E276. doi: 10.1002/lary.26561

Table 1.

Antibodies, concentrations, and immunohistochemistry protocols used to label muscle fibers

Primary antibodies and concentrations Reactivity Secondary antibodies and concentrations
BF-F8 (1:100)* I Alexa488 IgG2b, goat/anti-mouse (1:200)
BF-F3 (1:100)* IIb Alexa Fluor 594, IgG1, goat/anti-mouse (1:200)
6H1 (1:50)* IIx Alexa Fluor 594, IgG1, goat/anti-mouse (1:200)
SC-71 (1:100)* IIa Alexa488 IgG1, goat/anti-mouse (1:200)
MHC13 (1:50)*** IIeo Alexa488 IgG1, goat/anti-rabbit (1:200)
anti-laminin (1:200)** laminin Alexa405, goat/anti-rabbit IgG Invitrogen (1:100)

Targets Procedure Time

1. MHC I and IIb and laminin Phosphate buffer (PB) wash 2 × 2 min
Cold (4°C) methanol fixation 10 min
PB wash 2 × 2 min
Incubate in 10% normal goat serum in PB 1 hr
PB wash 2 × 2 min
Incubate in primary antibodies at 4°C overnight
PB wash 4 × 2 min
Incubate in secondary antibodies at RT 30 min
PB wash 3 × 2 min
Mount coverslips with Prolong Gold antifade reagent
1. MHC IIa and IIx and laminin Air dry 10 min
2. MHC IIeo Incubate in 10% normal goat serum in phosphate buffered saline (PBS) 1 hr
Incubate in primary antibodies at RT 2 hrs
PBS wash 3 × 5 min
Incubate in secondary antibodies at RT 1 hr
PBS wash 3 × 5 min
Mount coverslips with ProlongH Gold antifade reagent

Primary and secondary antibody cocktails were diluted in blocking buffer

*

Antibodies obtained from (Developmental Studies Hybridoma Bank, Iowa City, IA)

**

Antibodies obtained from (Sigma-Aldrich, St. Louis, MO)

***

Anitbodies obrain from (KY)

****

Antibodies obtained from (Invitrogen: Molecular Probes, Eugene, OR)